The value of serology testing to manage SARS-CoV-2 infections
Laia Fernández-Barat, Ruben López-Aladid, Antoni Torres
European Respiratory Journal 2020 56: 2002411; DOI: 10.1183/13993003.02411-2020
Laia Fernández-Barat
1Cellex Laboratory, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, 06/06/0028), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2School of Medicine, University of Barcelona, Barcelona, Spain
3Dept of Pneumology, Thorax Institute, Hospital Clinic of Barcelona, Barcelona, Spain
Ruben López-Aladid
1Cellex Laboratory, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, 06/06/0028), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2School of Medicine, University of Barcelona, Barcelona, Spain
3Dept of Pneumology, Thorax Institute, Hospital Clinic of Barcelona, Barcelona, Spain
Antoni Torres
1Cellex Laboratory, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, 06/06/0028), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2School of Medicine, University of Barcelona, Barcelona, Spain
3Dept of Pneumology, Thorax Institute, Hospital Clinic of Barcelona, Barcelona, Spain
Vol 56 Issue 2
Table of Contents
The value of serology testing to manage SARS-CoV-2 infections
Laia Fernández-Barat, Ruben López-Aladid, Antoni Torres
European Respiratory Journal Aug 2020, 56 (2) 2002411; DOI: 10.1183/13993003.02411-2020